EliseAOlsenMD

PubMed

• Treatment for central centrifugal cicatricial alopecia-Delphi consensus recommendations.
  Jackson, T., Sow, Y., Dinkins, J., Aguh, C., Omueti Ayoade, K., Barbosa, V., Burgess, C., Callender, V., Cotsarelis, G., Grimes, P., Harvey, V., Kindred, C., Lester, J...> ;Journal of the American Academy of Dermatology. 2024 Feb 9
• Bridging the specialty gap: Update on primary cutaneous lymphomas.
  Emmilia Hodak, Julia Scarisbrick, , Olsen, E., Geskin, L.> ;Journal of the American Academy of Dermatology. 2024 Feb 1
• 15 citations
  Efficacy and Safety of Topical Hypericin Photodynamic Therapy for Early-Stage Cutaneous T-Cell Lymphoma (Mycosis Fungoides): The FLASH Phase 3 Randomized Clinical Trial.
  Ellen J Kim, Aaron R Mangold, Jennifer A DeSimone, Henry K Wong, Lucia Seminario-Vidal, Joan Guitart, James Appel, Larisa Geskin, Edward Lain, Neil J Korman, Nathalie ...> ;JAMA Dermatology. 2022 Sep 1
• Ataxia-telangiectasia mutated (ATM) gene mutation in a patient with primary cutaneous marginal zone lymphoma.
  Melissa M Sarver, Kimberly F Breglio, Elise A Olsen> ;JAAD Case Reports. 2022 May 1
• 45 citations
  Primary Cutaneous Lymphoma: Recommendations for Clinical Trial Design and Staging Update from the ISCL, USCLC, and EORTC.
  Elise A. Olsen, Sean Whittaker, Rein Willemze, Lauren C. Pinter-Brown, Francine M. Foss, Larisa J. Geskin, Lawrence H. Schwartz, Steven M. Horwitz, Joan Guitart, John ...> ;Blood. 2021 Nov 10
• 11 citations
  Guidelines for clinical trials of frontal fibrosing alopecia: consensus recommendations from the International FFA Cooperative Group (IFFACG).
  Elise A. Olsen, Matthew Harries, Antonella Tosti, Wilma F. Bergfeld, Ulrike Blume-Peytavi, Valerie D. Callender, V. Chasapi, O. Correia, George Cotsarelis, Rachita Dhu...> ;The British Journal of Dermatology. 2021 Jun 9
• 30 citations
  The Alopecia Areata Consensus of Experts (ACE) study part II: Results of an international expert opinion on diagnosis and laboratory evaluation for alopecia areata.
  Nekma Meah, Dmitri Wall, Katherine York, Bevin Bhoyrul, Laita Bokhari, Daniel Asz-Sigall, Wilma F. Bergfeld, Regina C. Betz, Ulrike Blume-Peytavi, Valerie D. Callender...> ;Journal of the American Academy of Dermatology. 2021 Jun 1
• 13 citations
  A Global eDelphi Exercise to Identify Core Domains and Domain Items for the Development of a Global Registry of Alopecia Areata Disease Severity and Treatment Safety (...
  Dmitri Wall, Nekma Meah, Katherine York, Bevin Bhoyrul, Laita Bokhari, Leonardo Spagnol Abraham, Roisin Adams, Wilma F. Bergfeld, Regina C. Betz, Ulrike Blume-Peytavi,...> ;JAMA Dermatology. 2021 Apr 1
• 30 citations
  NCCN Guidelines Insights: T-Cell Lymphomas, Version 1.2021.
  Steven M. Horwitz, Stephen M. Ansell, Weiyun Z. Ai, Jeffrey A. Barnes, Stefan K. Barta, Mark W. Clemens, Ahmet Dogan, Aaron M. Goodman, Gaurav Goyal, Joan Guitart, Ahm...> ;Journal of the National Comprehensive Cancer Network. 2020 Nov 2
• 20 citations
  United States Cutaneous Lymphoma Consortium recommendations for treatment of cutaneous lymphomas during the COVID-19 pandemic.
  John A. Zic, Weiyun Z. Ai, Oleg E. Akilov, Joi B. Carter, Madeleine Duvic, Francine M. Foss, Michael Girardi, Alejandro A. Gru, Ellen Kim, Amy Musiek, Elise A. Olsen, ...> ;Journal of the American Academy of Dermatology. 2020 Aug 1
• 78 citations
  The Alopecia Areata Consensus of Experts (ACE) study: Results of an international expert opinion on treatments for alopecia areata
  Nekma Meah, Dmitri Wall, Katherine York, Bevin Bhoyrul, Laita Bokhari, Daniel Asz Sigall, Wilma F. Bergfeld, Regina C. Betz, Ulrike Blume-Peytavi, Valerie D. Callender...> ;Journal of the American Academy of Dermatology. 2020 Jul 1
• 55 citations
  Primary cutaneous lymphomas, version 2.2020. Featured updates to the NCCN guidelines
  Neha Mehta-Shah, Steven M. Horwitz, Stephen M. Ansell, Weiyun Z. Ai, Jeffrey A. Barnes, Stefan K. Barta, Mark W. Clemens, Ahmet Dogan, Kristopher R. Fisher, Aaron M. G...> ;Journal of the National Comprehensive Cancer Network. 2020 May 1
• 31 citations
  Ruxolitinib cream for the treatment of patients with alopecia areata: A 2-part, double-blind, randomized, vehicle-controlled phase 2 study
  Elise A. Olsen, Deanna Kornacki, Kang Sun, Maria K. Hordinsky> ;Journal of the American Academy of Dermatology. 2020 Feb 1
• 2 citations
  Focal atrichia: A diagnostic clue in female pattern hair loss.
  Elise A. Olsen, David A. Whiting> ;Journal of the American Academy of Dermatology. 2017 Oct 7
• 47 citations
  Female Pattern Hair Loss and Androgen Excess: A Report From the Multidisciplinary Androgen Excess and PCOS Committee
  Enrico Carmina, Ricardo Azziz, Wilma F. Bergfeld, Héctor F. Escobar-Morreale, Walter Futterweit, Heather G. Huddleston, Rogerio A. Lobo, Elise A. Olsen> ;The Journal of Clinical Endocrinology and Metabolism. 2019 Jul 1
• 37 citations
  NCCN Guidelines Insights: T-Cell Lymphomas, Version 2.2018
  Steven M. Horwitz, Stephen M. Ansell, Weiyun Z. Ai, Jeffrey A. Barnes, Stefan K. Barta, Michael Y. Choi, Mark W. Clemens, Ahmet Dogan, John P. Greer, Ahmad Halwani, Br...> ;Journal of the National Comprehensive Cancer Network. 2018 Feb 1
• 41 citations
  Objective Outcome Measures: Collecting Meaningful Data on Alopecia Areata
  Elise A. Olsen, Janet L. Roberts, Leonard C. Sperling, Antonella Tosti, Jerry Shapiro, Amy J. McMichael, Wilma F. Bergfeld, Valerie D. Callender, Paradi Mirmirani, Ken...> ;Journal of the American Academy of Dermatology. 2017 Nov 8
• 61 citations
  Primary cutaneous aggressive epidermotropic cytotoxic T-cell lymphomas: reappraisal of a provisional entity in the 2016 WHO classification of cutaneous lymphomas
  Joan Guitart, M. Estela Martinez-Escala, Antonio Subtil, Madeleine Duvic, Melissa Pulitzer, Elise A. Olsen, Ellen Kim, Alain H. Rook, Sara Samimi, Gary S. Wood, Michae...> ;Modern Pathology. 2017 May 1
• 43 citations
  SALT II: A new take on the Severity of Alopecia Tool (SALT) for determining percentage scalp hair loss
  Elise A. Olsen, Douglas Canfield> ;Journal of the American Academy of Dermatology. 2016 Dec 1
• 14 citations
  The state and consequences of dermatology drug prices in the United States
  Joerg Albrecht, Mark Lebwohl, Maryam M. Asgari, Daniel D. Bennett, Ashley Cook, Colby C. Evans, Lawrence Green, Julie A. Hodge, Arianne Shadi Kourosh, Mary E. Maloney,...> ;Journal of the American Academy of Dermatology. 2016 Sep 1
• 9 citations
  Efficacy and Safety of Once-Daily Minoxidil Foam 5% Versus Twice-Daily Minoxidil Solution 2% in Female Pattern Hair Loss: A Phase III, Randomized, Investigator-Blinded...
  Ulrike Blume-Peytavi, Jerry Shapiro, Andrew G. Messenger, Maria K. Hordinsky, Paul Zhang, Carlos Quiza, Uday Doshi, Elise A. Olsen> ;Journal of Drugs in Dermatology. 2016 Jul 1
• 128 citations
  Basal cell skin cancer, version 1.2016: Clinical practice guidelines in oncology
  Christopher K. Bichakjian, Thomas Olencki, Sumaira Z. Aasi, Murad Alam, James S. Andersen, Daniel Berg, Glen M. Bowen, Richard T. Cheney, Gregory A. Daniels, L. Frank ...> ;Journal of the National Comprehensive Cancer Network. 2016 May 1
• 112 citations
  Guidelines for phototherapy of mycosis fungoides and Sézary syndrome: A consensus statement of the United States Cutaneous Lymphoma Consortium
  Elise A. Olsen, Emilia Hodak, Thomas F. Anderson, Joi B. Carter, Marsha Henderson, Kevin D. Cooper, Henry W. Lim> ;Journal of the American Academy of Dermatology. 2016 Jan 1
• Cutaneous Lymphoma.
  Elise A Olsen> ;Dermatologic Clinics. 2015 Oct 1
• 40 citations
  Evaluation, Diagnosis, and Staging of Cutaneous Lymphoma.
  Elise A. Olsen> ;Dermatologic Clinics. 2015 Oct 1
• Join now to see all

Journal Articles

• Central Centrifugal Cicatricial Alopecia- What has been achieved, current clues for future research  
  Ogunleye TA, McMichael A, Olsen EA, African Skin and Hair Disorders, Dermatology Clinics, 1/1/2014
• Topical Chemotherapy in Cutaneous T-cell Lymphoma: Positive Results of a Pivotal Phase II trial testing the Efficacy and Safety of 002% Mechlorethamine Gel in Mycosis ...  
  Lessin SR, Duvic M, Guitart J, Pandya AG, Strober BE, Olsen EA, et al, JAMA Dermatol, 1/1/2013
• Denileukin Diftitox for the Treatment of CD25 Low-Expression Mycosis Fungoides and Sezary Syndrome  
  Prince HM, Martin AG, Olsen EA, Fivenson DP, Duvic M, Leuk Lymphoma, 1/1/2013
• The efficacy and safety of denileukin diftitox retreatment in patients with relapsed cutaneous T-cell lymphoma  
  Duvic M, Martin AG, Olsen EA, Fivenson DP, Prince HM, Leuk Lymphoma, 1/1/2013
• Cutaneous Gamma-delta T cell Lymphomas: A Spectrum of Presentations with Overlap with other Cytotoxic Lymphomas  
  Guitart J, Weisenburger DD, Subtil A, Kim E, Wood G, Duvic M, Olsen EA, et al, Am J Surg Pathol, 1/1/2012
• Subcutaneous interferon alfa for the treatment of cutaneous pseudolymphoma  
  Singletary HL, Selim A, Olsen E, Arch Dermatol, 1/1/2012
• Grading Dermatologic Adverse Events in Cancer Patients: The National Cancer Institute’s Common Terminology Criteria for Adverse Events Version 40  
  Chen A, Setser A, Andakat M, Cotliar J, Olsen EA, et al, J Am Acad Dermatol, 1/1/2012
• EORTC, ISCL, and USCLC consensus recommendations for the treatment of primary cutaneous CD30-positive lymphoproliferative disorders: lymphomatoid papulosis and primary...  
  Kempf W, Pfaltz K, Vermeer MH, Cozzio A, Ortiz-Romero PL, Bagot M, Olsen EA, et al, Blood, 1/1/2011
• Investigative guidelines for alopecia areata  
  Olsen EA, Dermatol Ther, 1/1/2011
• Treatment of chemotherapy-induced alopecia  
  Yeager CE, Olsen EA, Dermatol Ther, 1/1/2011
• Sezary Syndrome: Evaluation, Immunopathogenesis, Literature Review of Therapeutic Options and Recommendations for Therapy by the United States Cutaneous Lymphoma Conso...  
  Olsen EA, Rook AH, Zic J, Kim Y, Porcu P, Querfeld C, et al, J Am Acad Dermatol, 1/1/2011
• Clinical Endpoints and Response Criteria in Mycosis Fungoides and Sezary Syndrome: a Consensus Statement of the International Society for Cutaneous Lymphomas (ISCL), ...  
  Olsen EA, Whittaker S, Kim YH, Duvic M, Prince HM, Lessin SR, et al, J Clin Oncol, 1/1/2011
• An in-depth assessment of the impact of pruritus on the health-related quality of life of patients with cutaneous T-cell lymphoma  
  Demierre MF, Olsen EA, Williams C, Ardunio JM, McNaughton KS, J Support Oncol, 1/1/2011
• The United States Cutaneous Lymphoma Consortium (USCLC)  
  Olsen EA, Clinical Lymphoma, Myeloma, & Leukemia, 1/1/2010
• A proposed EGFR inhibitor dermatologic adverse event-specific grading scale from the MASCC Skin Toxicity Study Group  
  Lacouture M, Maitland M, Segaert S, Baran R, Fox L, Epstein J, Barasch A, Einhorn L, Wagner L, West D, Rapoport B, Kris M, Basch E, Eaby B, Kurtin S, Olsen EA, Dancey ..., Support Care Cancer, 1/1/2010
• Evaluation of the long-term tolerability and clinical benefit of vorinostat in patients with advanced cutaneous T-cell lymphoma (CTCL)  
  Duvic M, Olsen EA, Breneman D, Pacheo T, Parker S, Vonderheid E, Abuav R, Ricker J, Rizvi S, Cong C, Boileau K, Gunchenko A, Sanz-Rodriquez C, Geskin L, Clin Lymphoma Myeloma, 1/1/2009
• Central centrifugal cicatricial alopecia  
  Whiting DA, Olsen EA, Dermatol Ther, 1/1/2008
• Central scalp alopecia photographic scale in African American women  
  Olsen EA, Callendar V, Sperling L, McMichael A, Anstrom KJ, Bergfeld WD, Durden F, Roberts J, Shapiro J, Whiting DA, Dermatol Ther, 1/1/2008
• Review of the treatment of mycosis fungoides and Sezary syndrome: A Stage-Based Approach  
  Horwitz SM, Olsen EA, Duvic M, Porcu P, Kim YH, J Natl Compr Can Netw, 1/1/2008
• Revisions to the staging and classification of mycosis fungoides and Sezary Syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the C...  
  Olsen EA, Vonderheid E, Pimpinelli N, Willemze R, Kim Y, et al, Blood, 1/1/2007
• TNM classification system for primary cutaneous lymphomas other than mycosis fungoides and Sezary Syndrome: A proposal of the International Society for Cutaneous Lymph...  
  Kim YH, Willemze R, Pimpinelli N, Whittaker S, Olsen EA, Ranki A, Dummer R, and Hoppe RT for the ISCL and the EORTC, Blood, 1/1/2007
• A multicenter, randomized, placebo-controlled, double-blind clinical trial of a novel formulation of 5% Minoxidil Topical Foam vs placebo in the treatment of androgene...  
  Olsen EA, Whiting D, Bergfeld W, Miller J, Hordinsky M et al, J Am Acad Dermatol, 1/1/2007
• A Phase IIb multicenter trial of Vorinostat (Suberoylanilide Hydroxamic Acid, SAHA) in patients with persistent, progressive or treatment refractory mycosis fungoides ...  
  Olsen EA, Kim YH, Kuzel TM, Pacheco TR, Foss FM et al, J Clin Oncol, 1/1/2007
• The Many Faces of Cicatricial Alopecia  
  Olsen EA, Dermatology Focus, 1/1/2006
• A phase 2 open-label study of recombinant human interleukin-12 (rhIL-12) in patients with stage Ia, Ib, or IIa mycosis fungoides  
  Duvic M, Sherman ML, Wood GS, Kuzel TM, Olsen E, Foss F, Laliberte RJ, Ryan JL, Zonno K, and Rook AH, J Am Acad Dermatol, 1/1/2006
• Join now to see all

Lectures

• Hair Loss in Women 
  American Academy of Dermatology - Annual Meeting 2019 - Washington, D.C. - 3/2/2019
• Pennsylvania Academy of Dermatology and Dermatologic Surgery 45th Annual Meeting 
  Pennsylvania Academy of Dermatology and Dermatologic Surgery, Bedford, Pennsylvania - 9/21/2012

Other

• Clinical presentation, pathologic features, and diagnosis of S??zary syndrome 
  Olsen EA, Rook AH
  http://www.uptodate.com/contents/clinical-presentation-pathologic-features-and-diagnosis-of-sezary-s
  UpToDate, Wolters Kluwer Health - 2013-02-05